CareLit · DOI-Nachweis · Klinische Pädiatrie
Preclinical investigation of combination from the telomerase–inhibitor BRACO 20 with cisplatin and the effects of sole BRACO 20 treatment on neuroblastoma cells
DOI 10.1055/s-2004-828558
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Dullat, C Lanvers-Kaminsky, T Möllers, S Koling, A Schuck, C Poremba, J Boos
ZeitschriftKlinische Pädiatrie
Ausgabe05/2004
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The combined use of telomerase inhibitors and cytostatic drugs might be a new approach in the treatment of neuroblastomas. We investigated if neuroblastoma cells react more sensitive to a combination of the telomerase inhibitor BRACO20 and Cisplatin (CDPP) than to CDPP alone. Materials and Methods: Experiments were carried out with the neuroblastoma cell lines KCN and SHEP-SF. Toxicity of BRACO20 and/or CDDP w…
Zitieren
Zitierempfehlung
J Dullat, C Lanvers-Kaminsky, T Möllers, S Koling, A Schuck, C Poremba, J Boos (2004) Preclinical investigation of combination from the telomerase–inhibitor BRACO 20 with cisplatin and the effects of sole BRACO 20 treatment on neuroblastoma cells. Klinische Pädiatrie (05). https://doi.org/10.1055/s-2004-828558
Mit CareLit weiterarbeiten